Dr. Joseph Sirven, professor of neurology and Chairman Emeritus of the Department of Neurology at the Mayo Clinic in Arizona; Dr. Barry Gidal, professor of pharmacy and neurology at the University of Wisconsin-Madison; and Dr. Anup Patel, section chief of neurology at Nationwide Children’s Hospital in Columbus, Ohio, discuss clinical trials of Epidiolex, a purified cannabis-based medication for severe forms of epilepsy and the different ways to change the dosing for it.
About Epilepsy and Cannabis: Efficacy and Current Studies
Epilepsy.com’s contributors talk about studies conducted on cannabis and cannabidiol, including what has been learned about its effectiveness for treating Dravet and Lennox-Gastaut syndromes, contraindications, interactions with other medications, response rates, and side effects, as well as whether information from clinical studies can be applied to other epilepsy syndromes and dispensary versions of cannabis-related products.
